{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:58:38Z","timestamp":1785869918295,"version":"3.56.0"},"reference-count":25,"publisher":"Japanese Circulation Society","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2015]]},"DOI":"10.1253\/circj.cj-15-0475","type":"journal-article","created":{"date-parts":[[2015,9,6]],"date-time":"2015-09-06T22:01:17Z","timestamp":1441576877000},"page":"2353-2359","source":"Crossref","is-referenced-by-count":33,"title":["Clinical Significance of Early Recurrence After Pulmonary Vein Antrum Isolation in Paroxysmal Atrial Fibrillation\u3000\u2013 Insight Into the Mechanism \u2013"],"prefix":"10.1253","volume":"79","author":[{"given":"Shinsuke","family":"Miyazaki","sequence":"first","affiliation":[{"name":"Cardiovascular Center, Tsuchiura Kyodo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Tsuchiura Kyodo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Tsuchiura Kyodo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takamitsu","family":"Takagi","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Tsuchiura Kyodo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Iwasawa","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Tsuchiura Kyodo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Hachiya","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Tsuchiura Kyodo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Iesaka","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Tsuchiura Kyodo Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Ha\u00efssaguerre M, Ja\u00efs P, Shah DC, Garrigue S, Takahashi A, Lavergne T, et al. Electrophysiological end point for catheter ablation of atrial fibrillation initiated from multiple pulmonary venous foci. <i>Circulation<\/i> 2000; 101: 1409\u20131417.","DOI":"10.1161\/01.CIR.101.12.1409"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Nault I, Miyazaki S, Forclaz A, Wright M, Jadidi A, Ja\u00efs P, et al. Drugs vs. ablation for the treatment of atrial fibrillation: The evidence supporting catheter ablation. <i>Eur Heart J<\/i> 2010; 31: 1046\u20131054.","DOI":"10.1093\/eurheartj\/ehq079"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. JCS Joint Working Group. Guidelines for non-pharmacotherapy of cardiac arrhythmias (JCS 2011): Digest version. <i>Circ J<\/i> 2013; 77: 249\u2013274.","DOI":"10.1253\/circj.CJ-66-0054"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Miyazaki S, Taniguchi H, Kusa S, Uchiyama T, Nakamura H, Hachiya H, et al. Impact of atrial fibrillation termination site and termination mode in catheter ablation on arrhythmia recurrence. <i>Circ J<\/i> 2014; 78: 78\u201384.","DOI":"10.1253\/circj.CJ-13-0838"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Oral H, Knight BP, Ozaydin M, Tada H, Chugh A, Hassan S, et al. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. <i>J Am Coll Cardiol<\/i> 2002; 40: 100\u2013104.","DOI":"10.1016\/S0735-1097(02)01939-3"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Richter B, Gwechenberger M, Socas A, Marx M, G\u00f6ssinger HD. Frequency of recurrence of atrial fibrillation within 48 hours after ablation and its impact on long-term outcome. <i>Am J Cardiol<\/i> 2008; 101: 843\u2013847.","DOI":"10.1016\/j.amjcard.2007.11.021"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lellouche N, Ja\u00efs P, Nault I, Wright M, Bevilacqua M, Knecht S, et al. Early recurrences after atrial fibrillation ablation: Prognostic value and effect of early reablation. <i>J Cardiovasc Electrophysiol<\/i> 2008; 19: 599\u2013605.","DOI":"10.1111\/j.1540-8167.2008.01188.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Koyama T, Tada H, Sekiguchi Y, Arimoto T, Yamasaki H, Kuroki K, et al. Prevention of atrial fibrillation recurrence with corticosteroids after radiofrequency catheter ablation: A randomized controlled trial. <i>J Am Coll Cardiol<\/i> 2010; 56: 1463\u20131472.","DOI":"10.1016\/j.jacc.2010.04.057"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Saad EB, d\u2019Avila A, Costa IP, Aryana A, Slater C, Costa RE, et al. Very low risk of thromboembolic events in patients undergoing successful catheter ablation of atrial fibrillation with a CHADS2 score \u22643: A long-term outcome study. <i>Circ Arrhythm Electrophysiol<\/i> 2011; 4: 615\u2013621.","DOI":"10.1161\/CIRCEP.111.963231"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Andrade JG, Macle L, Khairy P, Khaykin Y, Mantovan R, De Martino G, et al. Incidence and significance of early recurrences associated with different ablation strategies for AF: A STAR-AF substudy. <i>J Cardiovasc Electrophysiol<\/i> 2012; 23: 1295\u20131301.","DOI":"10.1111\/j.1540-8167.2012.02399.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kornej J, Hindricks G, Kosiuk J, Arya A, Sommer P, Husser D, et al. Comparison of CHADS2, R2CHADS2, and CHA2DS2-VASc scores for the prediction of rhythm outcomes after catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry. <i>Circ Arrhythm Electrophysiol<\/i> 2014; 7: 281\u2013287.","DOI":"10.1161\/CIRCEP.113.001182"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Andrade JG, Khairy P, Macle L, Packer DL, Lehmann JW, Holcomb RG, et al. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: Insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial. <i>Circ Arrhythm Electrophysiol<\/i> 2014; 7: 69\u201375.","DOI":"10.1161\/CIRCEP.113.000586"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Maroto LC, Carnero M, Silva JA, Cobiella J, P\u00e9rez-Castellano N, Reguillo F, et al. Early recurrence is a predictor of late failure in surgical ablation of atrial fibrillation. <i>Interact Cardiovasc Thorac Surg<\/i> 2011; 12: 681\u2013686.","DOI":"10.1510\/icvts.2010.261842"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS\/EHRA\/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. <i>Heart Rhythm<\/i> 2012; 9: 632\u2013696.","DOI":"10.1016\/j.hrthm.2011.12.016"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Miyazaki S, Kuwahara T, Kobori A, Takahashi Y, Takei A, Sato A, et al. Long-term clinical outcome of extensive pulmonary vein isolation-based catheter ablation therapy in patients with paroxysmal and persistent atrial fibrillation. <i>Heart<\/i> 2011; 97: 668\u2013673.","DOI":"10.1136\/hrt.2009.186874"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Takagi T, Miyazaki S, Kusa S, Taniguchi H, Ichihara N, Iwasawa J, et al. Role of extended external auto-triggered loop recorder monitoring for atrial fibrillation: Validation and utility after catheter ablation procedures. <i>Circ J<\/i> 2014; 78: 2637\u20132642.","DOI":"10.1253\/circj.CJ-14-0610"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Patel D, Mohanty P, Di Biase L, Sanchez JE, Shaheen MH, Burkhardt JD, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. <i>Heart Rhythm<\/i> 2010; 7: 167\u2013172.","DOI":"10.1016\/j.hrthm.2009.10.025"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Takigawa M, Kuwahara T, Takahashi A, Watari Y, Okubo K, Takahashi Y, et al. Differences in catheter ablation of paroxysmal atrial fibrillation between males and females. <i>Int J Cardiol<\/i> 2013; 168: 1984\u20131991.","DOI":"10.1016\/j.ijcard.2012.12.101"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Verma A, Champagne J, Sapp J, Essebag V, Novak P, Skanes A, et al. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): A prospective, multicenter study. <i>JAMA Intern Med<\/i> 2013; 173: 149\u2013156.","DOI":"10.1001\/jamainternmed.2013.1561"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up? <i>J Am Coll Cardiol<\/i> 2011; 57: 160\u2013166.","DOI":"10.1016\/j.jacc.2010.05.061"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Richter B, Gwechenberger M, Socas A, Zorn G, Albinni S, Marx M, et al. Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation. <i>Clin Res Cardiol<\/i> 2012; 101: 217\u2013225.","DOI":"10.1007\/s00392-011-0383-3"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Lim HS, Schultz C, Dang J, Alasady M, Lau DH, Brooks AG, et al. Time course of inflammation, myocardial injury, and prothrombotic response after radiofrequency catheter ablation for atrial fibrillation. <i>Circ Arrhythm Electrophysiol<\/i> 2014; 7: 83\u201389.","DOI":"10.1161\/CIRCEP.113.000876"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jiang RH, Po SS, Tung R, Liu Q, Sheng X, Zhang ZW, et al. Incidence of pulmonary vein conduction recovery in patients without clinical recurrence after ablation of paroxysmal atrial fibrillation: Mechanistic implications. <i>Heart Rhythm<\/i> 2014; 11: 969\u2013976.","DOI":"10.1016\/j.hrthm.2014.03.015"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nakagawa H, Scherlag BJ, Patterson E, Ikeda A, Lockwood D, Jackman WM. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. <i>Heart Rhythm<\/i> 2009; 6(Suppl): S26\u2013S34.","DOI":"10.1016\/j.hrthm.2009.07.029"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Katritsis DG, Pokushalov E, Romanov A, Giazitzoglou E, Siontis GC, Po SS, et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: A randomized clinical trial. <i>J Am Coll Cardiol<\/i> 2013; 62: 2318\u20132325.","DOI":"10.1016\/j.jacc.2013.06.053"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/11\/79_CJ-15-0475\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T19:02:50Z","timestamp":1498244570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/79\/11\/79_CJ-15-0475\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-15-0475","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}